An inverse correlation of ERCC1 (one of the nucleotide excision repair pathway components) with response either to platinum therapy or to survival was clearly established in ovarian cancer [55,56], non-small cell lung cancer [57] and colorectal cancers [58]. Here, ERCC1 is linked to ovarian carcinoma.